Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Princess Private Equity Holding ( (GB:PEY) ) is now available.
Partners Group Private Equity Limited (PGPE Ltd) has announced its decision to exit its investment in PCI Pharma Services, a global contract development and manufacturing organization (CDMO), while reinvesting in the company’s next growth phase. The transaction, led by Bain Capital and Kohlberg & Company, values PGPE Ltd’s stake at approximately EUR 83 million, aligning with the latest carrying value. PGPE Ltd will reduce its exposure but reinvest EUR 18 million to support PCI’s future growth. This strategic move aims to further enhance PCI’s competitive positioning in the pharmaceutical and life sciences industry, leveraging its transformation into a global CDMO with advanced capabilities.
The most recent analyst rating on (GB:PEY) stock is a Sell with a EUR10.90 price target. To see the full list of analyst forecasts on Princess Private Equity Holding stock, see the GB:PEY Stock Forecast page.
More about Princess Private Equity Holding
PGPE Ltd, formerly known as Princess Private Equity Holding Limited, is an investment holding company founded in 1999 and based in Guernsey. It specializes in private equity direct investments and is managed by Partners Group, a global private markets investment management firm with over USD 150 billion in assets under management. PGPE Ltd is listed on the London Stock Exchange and aims to provide long-term capital growth and attractive dividends to its shareholders.
Average Trading Volume: 56,955
Technical Sentiment Signal: Hold
Find detailed analytics on PEY stock on TipRanks’ Stock Analysis page.